Literature DB >> 25055749

Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS).

Harnish P Patel1, Nasser Al-Shanti, Lucy C Davies, Sheila J Barton, Miranda D Grounds, Ross L Tellam, Claire E Stewart, Cyrus Cooper, Avan Aihie Sayer.   

Abstract

Sarcopenia is associated with adverse health outcomes. This study investigated whether skeletal muscle gene expression was associated with lean mass and grip strength in community-dwelling older men. Utilising a cross-sectional study design, lean muscle mass and grip strength were measured in 88 men aged 68-76 years. Expression profiles of 44 genes implicated in the cellular regulation of skeletal muscle were determined. Serum was analysed for circulating cytokines TNF (tumour necrosis factor), IL-6 (interleukin 6, IFNG (interferon gamma), IL1R1 (interleukin-1 receptor-1). Relationships between skeletal muscle gene expression, circulating cytokines, lean mass and grip strength were examined. Participant groups with higher and lower values of lean muscle mass (n = 18) and strength (n = 20) were used in the analysis of gene expression fold change. Expression of VDR (vitamin D receptor) [fold change (FC) 0.52, standard error for fold change (SE) ± 0.08, p = 0.01] and IFNG mRNA (FC 0.31; SE ± 0.19, p = 0.01) were lower in those with higher lean mass. Expression of IL-6 (FC 0.43; SE ± 0.13, p = 0.02), TNF (FC 0.52; SE ± 0.10, p = 0.02), IL1R1 (FC 0.63; SE ± 0.09, p = 0.04) and MSTN (myostatin) (FC 0.64; SE ± 0.11, p = 0.04) were lower in those with higher grip strength. No other significant changes were observed. Significant negative correlations between serum IL-6 (R = -0.29, p = 0.005), TNF (R = -0.24, p = 0.017) and grip strength were demonstrated. This novel skeletal muscle gene expression study carried out within a well-characterized epidemiological birth cohort has demonstrated that lower expression of VDR and IFNG is associated with higher lean mass, and lower expression of IL-6, TNF, IL1R1 and myostatin is associated with higher grip strength. These findings are consistent with a role of proinflammatory factors in mediating lower muscle strength in community-dwelling older men.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055749     DOI: 10.1007/s00223-014-9894-z

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

Review 1.  The pathogenetic bases of sarcopenia.

Authors:  Simona L Budui; Andrea P Rossi; Mauro Zamboni
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

2.  Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes.

Authors:  Peter M Abadir; Alka Jain; Laura J Powell; Qian-Li Xue; Jing Tian; Robert G Hamilton; David A Bennett; Thomas Finucane; Jeremy D Walston; Neal S Fedarko
Journal:  Circulation       Date:  2016-11-30       Impact factor: 29.690

Review 3.  Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs).

Authors:  Fausto Salaffi; Marina Carotti; Andrea Di Matteo; Luca Ceccarelli; Sonia Farah; Catalina Villota-Eraso; Marco Di Carlo; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2022-09-20       Impact factor: 6.313

Review 4.  The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.

Authors:  L A Consitt; B C Clark
Journal:  J Frailty Aging       Date:  2018

5.  Shared biological pathways for frailty and cognitive impairment: A systematic review.

Authors:  Lana Sargent; Mike Nalls; Angela Starkweather; Sarah Hobgood; Holly Thompson; Elaine J Amella; Andrew Singleton
Journal:  Ageing Res Rev       Date:  2018-08-10       Impact factor: 10.895

6.  Human Vastus Lateralis Skeletal Muscle Biopsy Using the Weil-Blakesley Conchotome.

Authors:  Alicja M Baczynska; Sarah Shaw; Helen C Roberts; Cyrus Cooper; Avan Aihie Sayer; Harnish P Patel
Journal:  J Vis Exp       Date:  2016-03-04       Impact factor: 1.355

Review 7.  Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences.

Authors:  A Stožer; P Vodopivc; L Križančić Bombek
Journal:  Physiol Res       Date:  2020-07-16       Impact factor: 1.881

8.  Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.

Authors:  John E Morley; Stefan D Anker; Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-10-22       Impact factor: 12.910

9.  Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy.

Authors:  Jenna M Bartley; Sarah J Pan; Spencer R Keilich; Jacob W Hopkins; Iman M Al-Naggar; George A Kuchel; Laura Haynes
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

Review 10.  Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing.

Authors:  Philipp Baumert; Mark J Lake; Claire E Stewart; Barry Drust; Robert M Erskine
Journal:  Eur J Appl Physiol       Date:  2016-06-13       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.